| abstract |
The present invention relates to novel pentacyclic heterocycle derivatives, tautomers or pharmaceutically acceptable salts thereof, their precursors and their pharmaceutical uses, represented by the compounds of formula (I). The novel pentacyclic derivatives, tautomers, pharmaceutically acceptable salts or precursors thereof according to the present invention exhibit anticancer activities and thus can be usefully used as anticancer agents. |